Zota Health Care Ltd. · NSE:ZOTA
Zota Health Care — Q4 FY21 Earnings Presentation
27 slides from Zota Health Care's earnings presentation, Jun 29, 2021
Slide 1: Letter to NSE: Investor Presentation submission
i-zoto' healthcare ltd. June 29,2021 To, The Manager Listing Department, The National Stock Exchange of lndia Limited Exchange Plaza, Bandra Kurla Complex, Bandra (E), Mumbai - 400051 Dear Sir/Madam, Trading Symbol: ZOTA Sub: lnvestor Presentation Ref: Regulation 30 of SEBI (Listing Obligations and
Slide 2: Q4 & FY21 Performance Highlights
Q4&FY21 PERFORMANCE HIGHLIGHTS JUNE 2021
Slide 3: Safe Harbour
Safe Harbour This presentation has been prepared by the Zota Health Care Limited (the “Company”) only for information purpose to the stakeholders and does not contain any offer or invitation to subscribe the securities of the Company. No offering of securities shall be made except by means of offer
Slide 4: Table Of Contents
Table Of Contents 01 RESULT HIGHLIGHTS 02 OPERATIONAL METRICS 03 DAVAINDIA BUSINESS OUTLOOK 04 & STRATEGY 05 FINANCIAL SUMMARY zotahealthcare.com
Slide 5: Q4FY21 - Result Highlights
Q4FY21- Result Highlights zotahealthcare.com
Slide 6: Consol Quarterly Financial Highlights
Consol Quarterly Financial Highlights Q-o-Q Revenues (₹ Lakhs) Gross Profit (%) Operating Profit (₹ Lakhs) PAT (₹ Lakhs) Q4-FY21 3064.26 Q4-FY21 29.57% Q4-FY21 -14.24 Q4-FY21 -68.06 Q3-FY21 3,048.27 Q3-FY21 29.78% Q3-FY21 -118.70 Q3-FY21 -100.79 Y-o-Y Revenues (₹ Lakhs) Gross Profit (%) Operating Pr
Slide 7: Revenue Break up – Quarterly
zotahealthcare.com Export Sales (SEZ) 1,013.4 Q4-FY21 1,020.3 Q3-FY21 536.4 Q4-FY20 Revenue Break up – Quarterly 768.7 Q4-FY21 Dava India Sales 693.5 Q3-FY21 325.0 Q4-FY20 1,282.2 Q4-FY21 Domestic Sales 1,334.5 Q3-FY21 1,446.5 Q4-FY20 06
Slide 8: FY - Result Highlights
FY- Result Highlights zotahealthcare.com
Slide 9: Consol Profit & Loss Statement - Quarterly
Consol Profit & Loss Statement - Quarterly Particulars (Rs Lakhs) Q4FY21 Q4FY20 YoY % QoQ % Q3FY21 Export Sales (SEZ) 1,013.4 536.4 89% -1% 1020.25 Dava India Sales 768.7 325.0 137% 11% 693.5 Domestic Sales 1,282.2 1,446.5 -11% -4% 1,334.52 Revenues from Operations 3,064.26 2,307.96 33% 1% 3,048.27
Slide 10: Management Commentary
Management Commentary 01 The new-age businesses of 02 This is in line with the 03 The sales contribution from the Company i.e. Dava India Company’s strategy of new-age business stands at and Exports have recorded increasing overall Revenue 58.14% in Q4FY21 as their best ever quarterly contribution f
Slide 11: Management Commentary
Management Commentary DOMESTIC OPERATIONS Domestic Revenues EBITDA at ₹ (170.87) PAT stood at at ₹ registered a growth of 15.77% Lakhs for Q4FY21 due (198.09) lakhs for at ₹ 2050.9 Lakhs YoY, due to to higher operational Q4FY21. higher revenue from expenses of Davainda operations. Davaindia. *Here,
Slide 12: Davaindia Generic Pharmacy
Davaindia Generic Pharmacy zotahealthcare.com
Slide 13: Davaindia Key Figures: Stores and SKUs
zotahealthcare.com 100 Q4-FY21 109 Q3-FY21 99 Q2-FY21 31 Q1-FY21 32 Q4-FY20 Stores rolled-out 45 Q3-FY20 33 Q2-FY20 Davaindia Key Figures 39 Q1-FY20 29 Q4-FY19 1,431 Q4-FY21 1,371 Q3-FY21 1,368 Q2-FY21 1,353 Q1-FY21 1,338 Q4-FY20 1,333 Q3-FY20 1,310 Q2-FY20 1,250 Q1-FY20 SKU’s 1,150 Q4-FY19 012
Slide 14: Davaindia Key Figures: Customers and Wallet Spend
zotahealthcare.com 4,40,458 Q4-FY21 3,23,395 Q3-FY21 No. of Customers Served 3,52,623 Q2-FY21 3,38,415 Q1-FY21 2,75,520 Q4-FY20 2,67,030 Q3-FY20 2,59,022 Q2-FY20 Davaindia Key Figures 2,21,975 Q1-FY20 2,31,100 Q4-FY19 204 Q4-FY21 209 Q3-FY21 181 Q2-FY21 Average Wallet Spend 164 Q1-FY21 159 Q4-FY20 1
Slide 15: Davaindia - Generic Pharmacy
Davaindia- Generic Pharmacy During the quarter Davaindia has Davaindia has led the revolution of Davaindia retail pharmacy stores’ catered to 4.40 lakhs customers patients opting for generic medicines focus continues to be chronic ailments against 2.75 lakhs in Q4FY20, coupled against branded counte
Slide 16: Davaindia - Generic Pharmacy
Davaindia- Generic Pharmacy 15 zotahealthcare.com
Slide 17: Davaindia - COCO Stores
Davaindia- COCO Stores 16 zotahealthcare.com
Slide 18: Davaindia Footprints
Davaindia Footprints 591 States Assam Bihar No. of Stores 04 03 TOTAL NUMBER OF STORES Chattisgarh 05 Goa 01 Gujarat 138 Haryana 25 Himachal Pradesh 03 Jharkhand 06 Karnataka 05 Kashmir 02 Kerala 11 Madhya Pradesh 84 Maharashtra 109 Meghalaya 01 New Delhi 43 Odisha 24 Punjab 09 Rajasthan 20 Tamil Na
Slide 19: Management Commentary
Management Commentary Commenting on Q4 and FY21 financial performance and operational highlights, Management Team of Zota Health Care said, “We are happy to report a great set of developments in a rather challenging year, as you all must be aware, FY21 has been a difficult year for consumer companie
Slide 20: Industry Snapshot & Business Strategy
Industry Snapshot & Business Strategy zotahealthcare.com
Slide 21: Retail Generic Medicine Landscape in India
Retail Generic Medicine Landscape in India To achieve the objective of making available quality generic medicines at affordable prices to all, ‘Jan Aushadhi Scheme’ was launched by the Department of Pharmaceuticals, Ministry of Chemicals & Fertilizers, Government of India across the county. The sche
Slide 22: Impact of PMBJP
Impact of PMBJP In the financial year (2019-20), PMBJP has achieved sales of ₹258 crores (at MRP), up to 30-11-2019. This has led to savings of approximately ₹1,800 crores of the common citizens of the country. Growth in number of stores Growth in turnover Product basket Price of Janaushadhi medicin
Slide 23: Underpenetrated Generic Medicine Market
Underpenetrated Generic Medicine Market 4 pillars to drive Branded and generic mix of Indian healthcare pharma market (%) Overall India Urban India Rural India 4 As of healthcare 8 6 15 1 Accessibility 2 Affordability 3 Awarness 4 Aliments 92 94 85 • Setting up of new • Higher per capita • Rising li
Slide 24: Financial Summary
Financial Summary zotahealthcare.com
Slide 25: Profit & Loss Statement
Profit & Loss Statement Particulars (INR Lakhs) FY15 FY16 FY17 FY18 FY19 FY20 FY21 Income from Operations 5,646.3 6,473.3 7,158.0 7,785.2 8,562.9 9,511.3 10678.92 Other Income 1.4 7.7 5.6 151.9 154.5 151.3 125.97 Total Income 5,647.8 6,481.0 7,163.6 7,937.0 8,717.4 9,662.6 10804.89 Operating Expense
Slide 26: Balance Sheet & Key Ratios
Balance Sheet & Key Ratios Particulars (INR Lakhs) FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 Share capital 1,196.9 1,436.3 1,436.3 1,436.3 1,754.3 1,754.3 2,456.0 2,456.0 Reserves and Surplus 384.2 395.7 707.8 1,262.0 5,223.4 5,138.2 4,426.9 4,173.6 Non-current liabilities 521.3 548.7 272.7 466.8 64.7
Slide 27: Thank You
Thank You Contact Information Mr. Himanshu Zota / Mr. Ashvin Variya "ZOTA HOUSE", 2/896, Hira Modi Street, Sagrampura, Surat-395 002(Gujarat) cszota@zotahealthcare.com www.zotahealthcare.com